JAVIER
GANDASEGUI ARAHUETES
Investigador/a en el periodo 2020-2021
![Foto de JAVIER](/img/nophoto.png)
![Foto de Wellcome Trust Sanger Institute](/img/noimage_org.png)
Wellcome Trust Sanger Institute
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de Wellcome Trust Sanger Institute (2)
2022
-
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Gates Open Research, Vol. 6
-
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control
The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347